Matches in SemOpenAlex for { <https://semopenalex.org/work/W176983039> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W176983039 endingPage "726" @default.
- W176983039 startingPage "715" @default.
- W176983039 abstract "A variety of treatments have recently been introduced to improve the prognosis of hepatocellular carcinoma (HCC). These anticancer therapies include the oily carcinostatic agent styrene maleic acid neocarzinostatin (SMANCS). SMANCS is a chemical conjugate of a synthetic copolymer of styrene maleic acid (SMA) and the proteinaceous anti-cancer agent neocarzinostatin (NCS), which dissolves in organic solvents such as pyridine and acetone, and particularly in Lipiodol. NCS is a simple protein capable of inhibiting DNA synthesis and inducing DNA degradation. Lipiodol is an ethyl ester of iodinated poppy seed oil in which most of the unsaturated double bonds in oleic, linoleic and linolenic acid are almost completely iodinated. When a homogeneous suspension of SMANCS with Lipiodol (SMANCS/Lipiodol) is administered intra-arterially, Lipiodol acts as a carrier of SMANCS. Many studies have demonstrated the clinical efficacy of SMANCS/Lipiodol in the treatment of HCC. We have shown that transcatheter arterial infusion (TAI) with SMANCS/Lipiodol has a more favorable focal therapeutic effect than does epirubicin in Lipiodol in the initial treatment of HCC. However, recent clinical studies have indicated that SMANCS causes severe adverse reactions and complications. We have also reported a case of HCC in which multifocal hepatic infarction developed after TAI with SMANCS/Lipiodol. Arterial administration of SMANCS/Lipiodol, therefore, should be given as peripherally as possible via the tumor feeding arteries, to enhance the efficacy of the agent and to reduce the adverse effects." @default.
- W176983039 created "2016-06-24" @default.
- W176983039 creator A5011562521 @default.
- W176983039 creator A5090954042 @default.
- W176983039 date "2002-11-01" @default.
- W176983039 modified "2023-10-13" @default.
- W176983039 title "Styrene Maleic Acid Neocarzinostatin Treatment for Hepatocellular Carcinoma" @default.
- W176983039 doi "https://doi.org/10.2174/1568011023353679" @default.
- W176983039 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12678722" @default.
- W176983039 hasPublicationYear "2002" @default.
- W176983039 type Work @default.
- W176983039 sameAs 176983039 @default.
- W176983039 citedByCount "37" @default.
- W176983039 countsByYear W1769830392012 @default.
- W176983039 countsByYear W1769830392014 @default.
- W176983039 countsByYear W1769830392015 @default.
- W176983039 countsByYear W1769830392016 @default.
- W176983039 countsByYear W1769830392017 @default.
- W176983039 countsByYear W1769830392018 @default.
- W176983039 countsByYear W1769830392019 @default.
- W176983039 countsByYear W1769830392021 @default.
- W176983039 countsByYear W1769830392022 @default.
- W176983039 countsByYear W1769830392023 @default.
- W176983039 crossrefType "journal-article" @default.
- W176983039 hasAuthorship W176983039A5011562521 @default.
- W176983039 hasAuthorship W176983039A5090954042 @default.
- W176983039 hasConcept C126322002 @default.
- W176983039 hasConcept C141071460 @default.
- W176983039 hasConcept C185592680 @default.
- W176983039 hasConcept C2776035437 @default.
- W176983039 hasConcept C2776694085 @default.
- W176983039 hasConcept C2776755627 @default.
- W176983039 hasConcept C2777392692 @default.
- W176983039 hasConcept C2778019345 @default.
- W176983039 hasConcept C2778448856 @default.
- W176983039 hasConcept C2780835546 @default.
- W176983039 hasConcept C552990157 @default.
- W176983039 hasConcept C55493867 @default.
- W176983039 hasConcept C71924100 @default.
- W176983039 hasConcept C98274493 @default.
- W176983039 hasConceptScore W176983039C126322002 @default.
- W176983039 hasConceptScore W176983039C141071460 @default.
- W176983039 hasConceptScore W176983039C185592680 @default.
- W176983039 hasConceptScore W176983039C2776035437 @default.
- W176983039 hasConceptScore W176983039C2776694085 @default.
- W176983039 hasConceptScore W176983039C2776755627 @default.
- W176983039 hasConceptScore W176983039C2777392692 @default.
- W176983039 hasConceptScore W176983039C2778019345 @default.
- W176983039 hasConceptScore W176983039C2778448856 @default.
- W176983039 hasConceptScore W176983039C2780835546 @default.
- W176983039 hasConceptScore W176983039C552990157 @default.
- W176983039 hasConceptScore W176983039C55493867 @default.
- W176983039 hasConceptScore W176983039C71924100 @default.
- W176983039 hasConceptScore W176983039C98274493 @default.
- W176983039 hasIssue "6" @default.
- W176983039 hasLocation W1769830391 @default.
- W176983039 hasLocation W1769830392 @default.
- W176983039 hasOpenAccess W176983039 @default.
- W176983039 hasPrimaryLocation W1769830391 @default.
- W176983039 hasRelatedWork W2024950405 @default.
- W176983039 hasRelatedWork W2065885722 @default.
- W176983039 hasRelatedWork W2071930786 @default.
- W176983039 hasRelatedWork W2076539243 @default.
- W176983039 hasRelatedWork W2327698432 @default.
- W176983039 hasRelatedWork W2410302194 @default.
- W176983039 hasRelatedWork W2412065511 @default.
- W176983039 hasRelatedWork W2419372864 @default.
- W176983039 hasRelatedWork W2533069716 @default.
- W176983039 hasRelatedWork W3134556008 @default.
- W176983039 hasVolume "2" @default.
- W176983039 isParatext "false" @default.
- W176983039 isRetracted "false" @default.
- W176983039 magId "176983039" @default.
- W176983039 workType "article" @default.